BIO-TECHNE Corp (TECH) › Capital ExpendituresBIO-TECHNE Corp (TECH) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $6.56M2010: $4.64M2011: $3.63M2012: $6.02M2013: $22.45M2014: $13.82M2015: $19.91M2016: $16.90M2017: $15.18M2018: $20.93M2019: $25.41M2020: $51.74M2021: $44.30M2022: $44.91M2023: $38.24M2024: $62.88M2025: $31.01M$31.01M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$31.01M-50.7%2024$62.88M+64.4%2023$38.24M-14.8%2022$44.91M+1.4%2021$44.30M-14.4%2020$51.74M+103.6%2019$25.41M+21.4%2018$20.93M+37.9%2017$15.18M-10.2%2016$16.90M-15.1%2015$19.91M+44.0%2014$13.82M-38.4%2013$22.45M+273.2%2012$6.02M+65.8%2011$3.63M-21.8%2010$4.64M-29.2%2009$6.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share